VIRIDIAN THERAPEUTICS INC (VRDN) Top Institutional Shareholders
VIRIDIAN THERAPEUTICS INC (VRDN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $2.11B in VRDN holdings during the latest filing period.
Fmr Llc is currently the largest disclosed institutional shareholder of VRDN tracked by InsiderSet, reporting ownership valued at approximately $300.82M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $256.99M, representing an estimated loss of -14.57% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 51% of the total disclosed VRDN value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., Bellevue Group Ag, and several other long-term asset managers with concentrated positions in VIRIDIAN THERAPEUTICS INC (VRDN).
This page ranks the largest institutional VRDN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
221
Total Reported Value
$2.11B
Largest Holder
Fmr Llc
Largest Position
$300.82M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
153
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Fmr Llc | 0.02% | 15,379,377 | $300,820,614 | $256,989,390 | -$43,831,224 | -14.57% | |
| Blackrock, Inc. | 0.00% | 7,831,475 | $153,183,651 | $130,863,947 | -$22,319,704 | -14.57% | |
| Bellevue Group Ag | 3.13% | 6,726,144 | $131,563,376 | $112,393,866 | -$19,169,510 | -14.57% | |
| State Street Corp | 0.00% | 4,672,885 | $91,401,631 | $78,083,908 | -$13,317,723 | -14.57% | |
| Vanguard Capital Management Llc | 0.00% | 4,167,201 | $81,510,452 | $69,633,929 | -$11,876,523 | -14.57% | |
| Fairmount Funds Management Llc | 5.53% | 3,914,458 | $76,566,798 | $65,410,593 | -$11,156,205 | -14.57% | |
| Venrock Adviser, Llc | 2.83% | 3,882,709 | $75,945,788 | $64,880,067 | -$11,065,721 | -14.57% | |
| Paradigm Biocapital Advisors Lp | 1.26% | 3,148,893 | $61,592,347 | $52,618,002 | -$8,974,345 | -14.57% | |
| Wellington Management Group Llp | 0.01% | 3,078,554 | $60,216,516 | $51,442,637 | -$8,773,879 | -14.57% | |
| Kynam Capital Management, Lp | 2.91% | 2,341,652 | $45,802,713 | $39,129,005 | -$6,673,708 | -14.57% | |
| Geode Capital Management, Llc | 0.00% | 2,333,213 | $45,646,175 | $38,987,989 | -$6,658,186 | -14.59% | |
| Citadel Advisors Llc | 0.03% | 2,318,234 | $45,344,657 | $38,737,690 | -$6,606,967 | -14.57% | |
| Balyasny Asset Management L.P. | 0.09% | 2,315,957 | $45,300,119 | $38,699,641 | -$6,600,478 | -14.57% | |
| Alliancebernstein L.P. | 0.01% | 1,392,072 | $43,321,281 | $23,261,523 | -$20,059,758 | -46.30% | |
| Novo Holdings A/S | 3.17% | 2,000,000 | $39,120,000 | $33,420,000 | -$5,700,000 | -14.57% | |
| Baker Bros. Advisors Lp | 0.22% | 1,971,678 | $38,566,022 | $32,946,739 | -$5,619,283 | -14.57% | |
| Tang Capital Management Llc | 1.78% | 1,792,626 | $35,063,765 | $29,954,780 | -$5,108,985 | -14.57% | |
| Fisher Asset Management, Llc | 0.01% | 1,768,295 | $34,587,849 | $29,548,209 | -$5,039,640 | -14.57% | |
| Vanguard Portfolio Management Llc | 0.00% | 1,641,477 | $32,107,290 | $27,429,081 | -$4,678,209 | -14.57% | |
| Goldman Sachs Group Inc | 0.00% | 1,591,945 | $31,138,445 | $26,601,401 | -$4,537,044 | -14.57% | |
| Avoro Capital Advisors Llc | 0.29% | 1,500,000 | $29,340,000 | $25,065,000 | -$4,275,000 | -14.57% | |
| Deep Track Capital, Lp | 0.56% | 1,393,944 | $27,265,545 | $23,292,804 | -$3,972,741 | -14.57% | |
| D. E. Shaw & Co., Inc. | 0.02% | 1,262,540 | $24,695,283 | $21,097,043 | -$3,598,240 | -14.57% | |
| Perceptive Advisors Llc | 0.45% | 1,170,829 | $22,901,415 | $19,564,553 | -$3,336,862 | -14.57% | |
| Bank Of America Corp | 0.00% | 1,163,615 | $22,760,310 | $19,444,007 | -$3,316,303 | -14.57% | |
| Deutsche Bank Ag\ | 0.01% | 1,032,316 | $20,192,100 | $17,250,000 | -$2,942,100 | -14.57% | |
| Adage Capital Partners Gp, L.L.C. | 0.03% | 970,018 | $18,973,552 | $16,209,001 | -$2,764,551 | -14.57% | |
| Loomis Sayles & Co L P | 0.02% | 927,717 | $18,146,144 | $15,502,151 | -$2,643,993 | -14.57% | |
| First Turn Management, Llc | 1.99% | 911,337 | $17,825,752 | $15,228,441 | -$2,597,311 | -14.57% | |
| Rice Hall James & Associates, Llc | 0.98% | 898,611 | $17,576,831 | $15,015,790 | -$2,561,041 | -14.57% | |
| Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc | 0.00% | 888,298 | $17,375,111 | $14,843,460 | -$2,531,651 | -14.57% | |
| Morgan Stanley | 0.00% | 870,162 | $17,020,372 | $14,540,407 | -$2,479,965 | -14.57% | |
| Charles Schwab Investment Management Inc | 0.00% | 727,937 | $14,238,448 | $12,163,827 | -$2,074,621 | -14.57% | |
| Eversept Partners, Lp | 0.92% | 713,269 | $13,951,542 | $11,918,725 | -$2,032,817 | -14.57% | |
| Candriam S.C.A. | 0.07% | 711,739 | $13,921,615 | $11,893,159 | -$2,028,456 | -14.57% | |
| Metlife Investment Management, Llc | 0.07% | 708,527 | $13,858,788 | $11,839,486 | -$2,019,302 | -14.57% | |
| Woodline Partners Lp | 0.05% | 700,929 | $13,710,171 | $11,712,524 | -$1,997,647 | -14.57% | |
| Northern Trust Corp | 0.00% | 696,999 | $13,633,300 | $11,646,853 | -$1,986,447 | -14.57% | |
| Federated Hermes, Inc. | 0.02% | 668,968 | $13,085,014 | $11,178,455 | -$1,906,559 | -14.57% | |
| Mpm Bioimpact Llc | 0.98% | 649,873 | $12,711,516 | $10,859,378 | -$1,852,138 | -14.57% | |
| Nuveen, Llc | 0.00% | 604,914 | $11,832,118 | $10,108,113 | -$1,724,005 | -14.57% | |
| Vanguard Fiduciary Trust Co | 0.00% | 591,225 | $11,564,361 | $9,879,370 | -$1,684,991 | -14.57% | |
| Parkman Healthcare Partners Llc | 1.13% | 557,936 | $10,913,228 | $9,323,111 | -$1,590,117 | -14.57% | |
| Elmind Capital, Lp | 2.97% | 534,931 | $10,463,250 | $8,938,697 | -$1,524,553 | -14.57% | |
| Dimensional Fund Advisors Lp | 0.00% | 529,763 | $10,354,920 | $8,852,340 | -$1,502,580 | -14.51% | |
| Exoduspoint Capital Management, Lp | 0.07% | 330,390 | $6,462,428 | $5,520,817 | -$941,611 | -14.57% | |
| Point72 Asset Management, L.P. | 0.01% | 322,836 | $6,314,672 | $5,394,590 | -$920,082 | -14.57% | |
| Pictet Asset Management Holding Sa | 0.01% | 314,031 | $6,142,446 | $5,247,458 | -$894,988 | -14.57% | |
| Panagora Asset Management Inc | 0.02% | 313,700 | $6,135,972 | $5,241,927 | -$894,045 | -14.57% | |
| Ubs Group Ag | 0.00% | 307,134 | $6,007,541 | $5,132,209 | -$875,332 | -14.57% |
Frequently asked questions about VRDN
Who owns the most VRDN stock?
The largest holders of VRDN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for VIRIDIAN THERAPEUTICS INC (VRDN).
Is VRDN widely held by superinvestors?
Many widely followed stocks like VRDN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly VRDN is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.